ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
August 2026
Nuclear Technology
July 2026
Fusion Science and Technology
Latest News
Launching into tomorrow: NRIC guides new era of research and deployment
In June 2025, the Department of Energy announced the Reactor Pilot Program, an authorization pathway that allowed reactor developers to partner with the DOE to get first-of-a-kind (FOAK) reactors built and tested. Soon after, the DOE rolled out a complementary Fuel Line Pilot Program, which aimed to fast-track fuel projects. In all, 20 projects were accepted into the new programs.
R. T. Santoro, R. A. Lillie, R. G. Alsmiller, Jr, J. M. Barnes
Nuclear Technology | Volume 47 | Number 3 | March 1980 | Pages 412-420
Technical Paper | Reactor | doi.org/10.13182/NT80-A32395
Articles are hosted by Taylor and Francis Online.
Two-dimensional discrete-ordinates calculations have been performed to determine the location and thickness of concrete shielding around the Tokamak Fusion Test Reactor neutral beam injectors. Two sets of calculations were performed, one to determine the dose equivalent rate on the roof and wall of the test cell building when no injectors are present, and one to determine the contribution to the dose equivalent rate at these locations from radiation streaming through the injection duct. Shielding the side and rear of the neutral beam injector with 0.305 and 0.61 m of concrete, respectively, and lining the inside of the test cell wall with an additional layer of concrete having a thickness of 0.305 m and a height above the axis of deuteron injection of 3.10 m is sufficient to maintain the biological dose equivalent rate outside the test cell to ∼1 mrem/D-T pulse.